Comparison of 'time within therapeutic INR range' with 'percentage INR within therapeutic range' for assessing long-term anticoagulation control in children

被引：11
|
作者：
Biss, T. T. [1 ]
Avery, P. J. [2 ]
Walsh, P. M. [3 ]
Kamali, F. [1 ]
机构：
[1] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Newcastle Upon Tyne Hosp NHS Trust, Dept Paediat Cardiol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷 / 05期
关键词：
WARFARIN MANAGEMENT; PEDIATRIC-PATIENTS; SELF-MANAGEMENT; COHORT; HOME;
D O I：
10.1111/j.1538-7836.2011.04248.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1090 / 1092
页数：3
相关论文
共 50 条
  • [21] Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service
    Phelps, Elise
    Delate, Thomas
    Witt, Daniel M.
    Shaw, Paul B.
    McCool, Kathleen H.
    Clark, Nathan P.
    THROMBOSIS RESEARCH, 2018, 163 : 54 - 59
  • [22] Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations within Ninety Days of Renal Transplant
    Patel, S.
    Khali, K.
    Liehvar, A.
    Benedetti, E.
    West-Thielke, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 685 - 686
  • [23] A patient-specific tailored intervention improves INR time in therapeutic range and INR variability in heart failure patients: a randomized controlled trial
    Gotsman, I.
    Ezra, O.
    Hirsh-Rokach, B.
    Admon, D.
    Lotan, C.
    Ganz, F. Dekeyser
    EUROPEAN HEART JOURNAL, 2017, 38 : 1067 - 1067
  • [24] Factors associated with time in therapeutic INR range in patients with left ventricular assist devices anticoagulated with warfarin
    Newsom, Lydia
    Momary, Kathryn M.
    Paciullo, Christopher
    PHARMACOTHERAPY, 2013, 33 (10): : E263 - E263
  • [25] Effect of amiodarone on the time in therapeutic INR range for patients initiated on warfarin, results of the Michigan anticoagulation quality improvement initiative (MAQI2)
    Kaatz, S.
    Kobeissy, A.
    Barnes, G. D.
    Gu, X.
    Hickman, L.
    Almany, S.
    Kozlowski, J.
    Besley, D.
    Novakosky, M.
    Leyden, T.
    Froehlich, J. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 634 - 635
  • [26] Changes in Time in Therapeutic Range Within a Warfarin Anticoagulation Clinic Following Introduction of Direct Oral Anticoagulants
    Samuel, Preethi
    Cassidy, Kaitlyn
    Lazarevskiy, Pauletta
    Cope, Rebecca
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (06) : 1311 - 1317
  • [27] The control of parameters within the therapeutic range in neuromuscular electrical stimulation
    Han, Tai Ryoon
    Kim, Dai-Youl
    Lim, Suk Jin
    Lee, Kyu Jin
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2007, 117 (01) : 107 - 119
  • [28] A comparison of two efficacy measures of anticoagulation therapy: time in therapeutic range and percent of tests in range
    Wurster, Mark W.
    Heydman, Matthew
    Chopin, Barbara
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 394 - 394
  • [29] Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
    Kim, Esther
    Do, Tiffanie
    Peacock, Katie
    Takundwa, Prisca T.
    CUREUS, 2016, 8 (09):
  • [30] Tacrolimus time in therapeutic range and long-term outcomes in heart transplant recipients
    Adie, Sarah K.
    Bitar, Abbas
    Konerman, Matthew C.
    Dorsch, Michael P.
    Andrews, Chris A.
    Pogue, Kristen
    Park, Jeong M.
    PHARMACOTHERAPY, 2022, 42 (02): : 106 - 111
12345